Hematocrit As a Simple Method to Predict and Manage Ovarian Hyperstimulation Syndrome in Assisted Reproduction

Overview

Journal J Hum Reprod Sci

Date 2015 Jul 10

PMID 26157300

Citations 2

Authors

Taswin Kaur

Praveena Pai

Pratap Kumar

Affiliations

Soon will be listed here.

Abstract

Aim: The aim was to analyze the hematocrit levels in cases of ovarian hyperstimulation syndrome (OHSS), syndrome occurring during in-vitro fertilization (IVF), and study its role as a prognostic indicator.

Subjects And Methods: Two years data of 66 women at high risk for developing OHSS was analyzed. Twenty-seven women who developed OHSS were further analyzed based on their hematocrit levels on the day of oocyte pick-up (OPU) and the day of embryo transfer (ET) to see if there was a prognostic trend.

Results: Of the total 225 IVF cases, 66 were deemed high risk for developing OHSS. Twenty-seven of these developed OHSS (40.9%). Of these 27, 21 (77.8%) had a hematocrit >35% on the day of OPU. The mean hematocrit in women developing OHSS on the day of OPU was 37.39% (standard deviation [SD] 2.66) as against 35.97% (2.80) in those not developing OHSS. This difference was statistically significant (P = 0.043). On the day of ET, 23/27 (85.8%) who developed OHSS had a hematocrit of >35%. The mean hematocrit was 39.29% (SD 3.85) in those who developed OHSS as against 34.7% (2.88) in those who did not. This difference (4.85) was statistically significant (P < 0.001).

Conclusions: Women undergoing IVF were at a higher risk of developing OHSS when their hematocrit on the day of OPU and ET was >35%. Those who required cancellation of ET had a hematocrit of >35% on the day of ET or showed a significant increase of 3% from OPU to ET.

Citing Articles

High Maternal Neonatal Mortality and Morbidity in Pregnancy with Eisenmenger Syndrome.

Dachlan E, Amirah , Cininta N, Pranadyan R, Putri A, Oktaviono Y J Pregnancy. 2021; 2021:3248850.

PMID: 34616573 PMC: 8490032. DOI: 10.1155/2021/3248850.

The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome.

Bourgneuf C, Bailbe D, Lamaziere A, Dupont C, Moldes M, Farabos D Nat Commun. 2021; 12(1):1064.

PMID: 33594056 PMC: 7886868. DOI: 10.1038/s41467-021-21308-y.

References

Jayaprakasan K, Jayaprakasan R, Al-Hasie H, Clewes J, Campbell B, Johnson I . Can quantitative three-dimensional power Doppler angiography be used to predict ovarian hyperstimulation syndrome?. Ultrasound Obstet Gynecol. 2009; 33(5):583-91. DOI: 10.1002/uog.6373. View

Delvigne A, Rozenberg S . Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002; 8(6):559-77. DOI: 10.1093/humupd/8.6.559. View

Fiedler K, Ezcurra D . Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012; 10:32. PMC: 3403873. DOI: 10.1186/1477-7827-10-32. View

Devroey P, Polyzos N, Blockeel C . An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod. 2011; 26(10):2593-7. DOI: 10.1093/humrep/der251. View

Kaiser U . The pathogenesis of the ovarian hyperstimulation syndrome. N Engl J Med. 2003; 349(8):729-32. DOI: 10.1056/NEJMp038106. View

Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simon C . The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Fertil Steril. 1999; 71(3):482-9. DOI: 10.1016/s0015-0282(98)00484-1. View

Kumar P, Farouk Sait S, Sharma A, Kumar M . Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011; 4(2):70-5. PMC: 3205536. DOI: 10.4103/0974-1208.86080. View

Chen C, Wu M, Chao K, Chen S, Ho H, Yang Y . Serum estradiol level and oocyte number in predicting severe ovarian hyperstimulation syndrome. J Formos Med Assoc. 1997; 96(10):829-34. View

Courbiere B, Oborski V, Braunstein D, Desparoir A, Noizet A, Gamerre M . Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study. Fertil Steril. 2011; 95(5):1629-32. DOI: 10.1016/j.fertnstert.2010.12.015. View

10.

Navot D, Bergh P, Laufer N . Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 1992; 58(2):249-61. DOI: 10.1016/s0015-0282(16)55188-7. View

11.

Moos J, rezabek K, Filova V, Moosova M, Pavelkova J, Peknicova J . Comparison of follicular fluid and serum levels of Inhibin A and Inhibin B with calculated indices used as predictive markers of Ovarian Hyperstimulation Syndrome in IVF patients. Reprod Biol Endocrinol. 2009; 7:86. PMC: 2744919. DOI: 10.1186/1477-7827-7-86. View

12.

Papanikolaou E, Pozzobon C, Kolibianakis E, Camus M, Tournaye H, Fatemi H . Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006; 85(1):112-20. DOI: 10.1016/j.fertnstert.2005.07.1292. View

13.

Verit F, Cetin O, Yildirim O, Keskin S, Yucel O, Yalcinkaya S . Neutrophil to lymphocyte ratio is superior to platelet to lymphocyte ratio as an early predictor of moderate/severe ovarian hyperstimulation syndrome. J Obstet Gynaecol. 2014; 34(7):639-43. DOI: 10.3109/01443615.2014.920792. View

14.

Golan A, Weissman A . Symposium: Update on prediction and management of OHSS. A modern classification of OHSS. Reprod Biomed Online. 2009; 19(1):28-32. DOI: 10.1016/s1472-6483(10)60042-9. View

15.

Chang P, Kenley S, Burns T, Denton G, Currie K, Devane G . Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro.... Fertil Steril. 2001; 76(1):67-74. DOI: 10.1016/s0015-0282(01)01851-9. View

16.

Humaidan P, Quartarolo J, Papanikolaou E . Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril. 2010; 94(2):389-400. DOI: 10.1016/j.fertnstert.2010.03.028. View

17.

Lee T, Liu C, Huang C, Wu Y, Shih Y, Ho H . Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2007; 23(1):160-7. DOI: 10.1093/humrep/dem254. View